Hanmi Financial buy krebskrebs
Start price
02.06.20
/
50%
€8.15
Target price
04.11.21
€8.00
Performance (%)
150.75%
End price
05.11.21
€19.90
Summary
This prediction ended on 05.11.21 with a price of €19.90. With a performance of 150.75% the BUY prediction by krebskrebs was a big success. Dividends of €0.54 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hanmi Financial | 1.471% | 1.471% | 38.693% | 69.325% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
Comments by krebskrebs for this prediction
In the thread Hanmi Financial diskutieren
Buy mit Kursziel 8,0
In the thread Trading Hanmi Financial
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

